Onyx Healthcare Inc. (TPEX:6569)
109.00
+0.50 (0.46%)
Aug 15, 2025, 2:31 PM CST
Onyx Healthcare Revenue
Onyx Healthcare had revenue of 357.47M TWD in the quarter ending June 30, 2025, with 19.42% growth. This brings the company's revenue in the last twelve months to 1.33B, down -3.46% year-over-year. In the year 2024, Onyx Healthcare had annual revenue of 1.24B, down -16.85%.
Revenue (ttm)
1.33B
Revenue Growth
-3.46%
P/S Ratio
3.19
Revenue / Employee
11.12M
Employees
120
Market Cap
4.25B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1.24B | -251.61M | -16.85% |
Dec 31, 2023 | 1.49B | -107.41M | -6.71% |
Dec 31, 2022 | 1.60B | 398.51M | 33.16% |
Dec 31, 2021 | 1.20B | -145.54M | -10.80% |
Dec 31, 2020 | 1.35B | -135.64M | -9.15% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Caliway Biopharmaceuticals | 44.83M |
PharmaEssentia | 12.63B |
Bora Pharmaceuticals Co., LTD. | 21.32B |
Lotus Pharmaceutical | 19.12B |
Oneness Biotech | 112.57M |
Lumosa Therapeutics | 37.25M |
Polaris Group | 87.67M |
Center Laboratories | 1.63B |